Skip to content
MarketScale
‹ Back to IndustriesSciences

Fifty Years Later, The Space Race is Back On

In the time since Neil Armstrong and Buzz Aldrin first landed on the moon on July 20, 1969, only 10 other men have walked on the lunar surface. Fifty years after this marvel of human achievement, there is a new desire to go back, not simply for exploration’s sake, but for commercial reasons. Never before…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Geoff Short · Apollo 11Blue OriginBuzz AldrinElon Musk
Share
Fifty Years Later, The Space Race is Back On

Key takeaways

01

In the time since Neil Armstrong and Buzz Aldrin first landed on the moon on July 20, 1969, only 10 other men have walked on the lunar surface.

02

Fifty years after this marvel of human achievement, there is a new desire to go back, not simply for exploration’s sake, but for commercial reasons.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

In the time since Neil Armstrong and Buzz Aldrin first landed on the moon on July 20, 1969, only 10 other men have walked on the lunar surface. Fifty years after this marvel of human achievement, there is a new desire to go back, not simply for exploration’s sake, but for commercial reasons.

Never before have there been as many space-oriented startups as there are today, and public-private relationships are developing quickly across the United States.

The Public-Private Push

The Trump administration has laid out a plan to return to the moon by 2024 with the goal to have a sustained presence by 2028, and entrepreneurs are racing climb aboard. Whether this is a realistic goal remains to be seen.

Billionaires Elon Musk and Jeff Bezos have publicly led the movement with their companies SpaceX and Blue Origin, respectively. Entrepreneurs from across the globe, and the venture capitalists backing them see an opportunity for tourism among the stars, resource mining, and a potential launching pad to planets including Mars.

For the first time since the 1960s, a genuine space race is officially heating up.

According to the Wall Street Journal, 90 percent of the $8.4 billion that has been spent by venture capitalists on space startups has been done in the past five years alone.

The Uncertain Horizon

Still, questions remain about the return on investment of the moon. With uncertainty about the timeline and ultimate plans, some investors remain leery.

The U.S. government however, seeing China and Russia gear up for trips to the moon, has little choice but to hand out contracts to private companies intent on getting there quickly.

Startups with application in everything from defense to hospitality are vying for access to the moon and Mars, and competition is accelerating the process of a return to the lunar surface.

For more on the space race head to our science page!

Make sure to follow us on Twitter at @ScienceMKSL.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

GS
Geoff Short

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

AeroVironment is building three Mars helicopters, and the supply chain looks like defense

AeroVironment is building three Mars helicopters, and the supply chain looks like defense

AeroVironment’s MacCready Works has been contracted to build three autonomous Mars helicopters for NASA's SkyFall mission. This development highlights the company's capabilities in aerospace-grade autonomy and avionics integration. The project shows a strong connection between aerospace and defense industries in terms of supply chain management.

  • 01AeroVironment is constructing three autonomous helicopters for NASA's Mars mission.
  • 02The supply chain for these helicopters mirrors that of the defense industry.
  • 03Aerospace-grade autonomy and avionics integration are key features of AeroVironment's project.

Aug 29, 2026

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Pharmaceutical companies are increasingly using telehealth digital waiting rooms as prime advertising slots. These virtual spaces offer unique opportunities for pharma brands to engage patients before and after their virtual care visits. The trend is driven by fresh data on patient attention and strategic execution by agencies.

  • 01Pharmaceutical brands are using digital waiting rooms in telehealth platforms as premium ad slots.
  • 02New patient-attention data enhances pharma media plans for virtual care settings.
  • 03Virtual waiting rooms allow targeted patient engagement before and after healthcare consultations.

Aug 29, 2026

Roche pTau217 clearance and Labcorp’s Alzheimer’s test bring diagnostics to primary care

Roche pTau217 clearance and Labcorp’s Alzheimer’s test bring diagnostics to primary care

Recent advancements in Alzheimer’s pathology tests and lab automation are transforming diagnostics by moving the bottleneck from assay availability to workflow activation. These developments are making it feasible for primary care facilities to access cutting-edge diagnostic tools. This shift promises to enhance early detection and treatment strategies for Alzheimer's disease.

  • 01Lab automation is helping to remove bottlenecks in workflow activation for Alzheimer’s diagnostics.
  • 02Primary care facilities are gaining access to advanced Alzheimer’s diagnostic tests.
  • 03Early detection and treatment of Alzheimer's disease could be improved by these new diagnostic tools.

Aug 28, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

GS
Geoff Short

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512